Conference Coverage
Shorter H pylori Treatment With Vonoprazan Shows Better Results
The triple therapy regimen with vonoprazan was generally better tolerated than the 14-day omeprazole-based regimen.
Heartburn/Acid Reflux
Latest News
No Link Between PPI Use and Risk for Cardiovascular Events
Patients with gastroesophageal reflux disease do experience a slight increase in cardiovascular events with PPI use, the researchers noted.
Conference Coverage
Cendakimab That Targets IL-13 Shows Promise in Eosinophilic Esophagitis
Treatment with cendakimab also improved key endoscopic and histologic features, even in patients who had an inadequate response or intolerance to...
Sponsored Supplement
Reducing Symptom Burden for Patients with Indolent Systemic Mastocytosis, a Chronic Mast Cell Disorder
From the Journals
Acid Blockers Appear Superior to PPIs in Erosive Esophagitis
Both potassium-competitive acid blockers and PPIs showed better healing rates at 4 and 8 weeks than placebo.
News from the FDA/CDC
FDA OKs Voquezna for Heartburn Relief in Nonerosive Gastroesophageal Reflux Disease
The approval in nonerosive GERD was supported by results of the PHALCON-nonerosive GERD-301 study.
Latest News
Gene Tests Could Predict if a Drug Will Work for a Patient
Pharmacogenetics could help physicians determine which patients would and would not benefit from medications.
Latest News
Menopause, RSV, and More: 4 New Meds to Know
New treatments have been approved to treat conditions including GERD, depression, RSV vaccines, and hot flashes with menopause.
Latest News
Erosive Esophagitis: 5 Things to Know
Physician shares risk factors, potential therapies, and complications of EE.
Latest News
How Does Diet Affect Gastroesophageal Reflux Disease?
Diets low in fats and carbohydrates should be recommended as producing the fewest GERD symptoms.
From the Journals
Swallow this: Tiny tech tracks your gut in real time
Part of what makes gastrointestinal troubles so frustrating are the invasive and uncomfortable tests one must endure for diagnosis.
From the Journals
PPI use in type 2 diabetes links with cardiovascular events
Prospective data from almost 20,000 people with type 2 diabetes show that proton pump inhibitor use is linked with significantly more...
Sponsored Supplement
Pharmacogenomic Testing in Depression Treatment Decision Making: Clinical Pearls for Everyday Practice
Latest News
How can clinicians distinguish food allergy and GERD in young kids?
“Many allergists fear that patients may be labeled with a food allergy unnecessarily. Because no biomarkers or tests for food allergy–related GERD...
Latest News
Childhood cow’s milk allergy raises health care costs
“Children with food allergies typically have other atopic comorbidities that require more visits to primary care physicians and specialists and...
From the Journals
Study pinpoints best predictor of when reflux symptoms don’t require PPI
Acid exposure time less than 4.0% measured over 4 days was the best predictor of when patients don’t need PPI therapy.
Applied Evidence
Dyspepsia: A stepwise approach to evaluation and management
Let a patient’s age and specific symptoms steer your initial investigation. Consider treatment options beyond antibiotics for H pylori gastritis...
Feature
Microbiome startups promise to improve your gut health, but is the science solid?
Consumers pay hundreds of dollars for tests not covered by insurance, hoping to get answers to health problems ranging from irritable bowel...
From the Journals
PPIs associated with diabetes risk, but questions remain
Researchers call for blood glucose testing and diabetes surveillance in long-term PPI users, but causal evidence is weak.